Clinical Trial Update: Octreotide Microspheres for Preventing Pancreatic Fistula [Phase 3]

View source ↗

Summary

This clinical trial entry describes a Phase 3 study of octreotide microspheres aimed at preventing pancreatic fistula, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Fistula

Drugs mentioned

• Octreotide microspheres (octreotide)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Pancreatic Fistula | Phase 3 | Status: NOT_YET_RECRUITING